MNX1-AS1 and ovarian carcinoma: Using an ovarian cancer dataset, we show that MAYA identifies several modes of pathway activation shared across patients (Fig. 5a–c and Supplementary Fig. 5a, b) that are associated with known cancer hallmarks.